addit
observ
protect
immun
mice
challeng
mouseadapt
aiv
influenza
viru
evidenc
reduct
lung
viru
titer
improv
lung
patholog
weight
loss
complet
surviv
data
promis
gener
effect
nontradit
influenza
vaccin
aiv
regul
activ
statu
dc
improv
dc
function
evalu
potenti
effect
dc
mous
dc
gener
bone
marrow
cell
activ
mous
dc
invitro
evalu
use
gate
strategi
shown
fig
cocultur
mous
dc
elicit
signific
enhanc
express
marker
mous
dc
fig
c
induc
full
cell
activ
second
signal
costimulatoryregulatori
molecul
dc
import
mice
oral
inocul
l
plantarum
express
anaesthesia
h
inocul
pp
mesenter
lymph
node
mln
intestin
collect
cell
label
mhcii
analys
express
molecul
determin
frequenc
activ
marker
dc
compar
control
induc
notabl
enhanc
surfac
express
mhcii
cell
lamina
propria
small
intestin
h
postvaccin
fig
howev
contrast
mln
dc
present
pp
h
postvaccin
fig
c
furthermor
h
postvaccin
greater
frequenc
mhcii
dc
observ
mln
mice
treat
data
shown
data
also
impli
dc
activ
initi
occur
small
intestin
pp
follow
oral
administr
activ
dc
subsequ
migrat
mln
increas
express
dc
activ
marker
may
indic
function
matur
apc
specif
antibodi
titer
np
antigen
mice
oral
immun
l
plantarum
express
three
time
primer
vaccin
four
week
primer
vaccin
mice
receiv
three
booster
immun
fourteen
day
last
booster
immun
observ
significantli
increas
number
iga
b
cell
pp
group
compar
group
fig
addit
antibodi
content
also
detect
day
primer
vaccin
total
iga
respons
excrement
induc
group
detect
elisa
compar
group
signific
increas
iga
antibodi
level
observ
excrement
group
fig
furthermor
higher
iga
titer
observ
faec
bronchoalveolar
lavag
fluid
balf
mice
receiv
inactiv
vaccin
compar
pb
group
fig
increas
ileal
iga
detect
mice
vaccin
recombin
vaccin
correl
induct
mucos
immun
respons
fig
ab
respons
might
relat
germin
center
gc
ln
spleen
mice
immun
recombin
bacteria
pp
mln
collect
mous
five
day
postprim
vaccin
mln
pp
cell
immun
control
group
mice
gate
fa
pna
b
cell
proport
fa
pna
b
cell
pp
fig
mln
fig
significantli
higher
group
immun
mice
compar
pb
control
group
addit
proport
fa
pna
b
cell
drain
lymph
node
dln
spleen
significantli
higher
group
receiv
recombin
bacteria
inactiv
vaccin
pb
group
data
shown
data
demonstr
gc
develop
lymph
node
oral
vaccin
l
plantarum
evalu
cellmedi
immun
respons
elicit
oral
immun
control
specif
enzymelink
immunospot
elispot
respons
specif
np
epitop
aiv
spleen
mln
analys
two
week
booster
immun
mice
vaccin
exhibit
significantli
higher
proport
result
present
mean
sem
triplic
test
n
mice
group
analys
use
oneway
anova
assum
gaussian
distribut
follow
bonferroni
posttest
statist
signific
differ
group
analys
p
p
p
local
immun
respons
induc
recombin
vaccin
mice
oral
administ
strain
harbour
plasmid
indic
day
boost
day
fourteen
day
booster
immun
number
iga
cell
pp
measur
flow
cytometri
n
b
total
siga
faec
measur
elisa
n
group
day
primer
immun
c
specif
siga
titr
faecc
balf
analys
day
primer
vaccin
n
result
present
mean
sem
analys
use
oneway
anova
assum
gaussian
distribut
follow
dunnett
posttest
express
rel
valu
pb
inactiv
vaccin
p
p
p
data
shown
repres
one
three
experi
equival
result
produc
cell
mln
spleen
respons
stimul
specif
epitop
np
compar
group
except
inactiv
vaccin
group
fig
b
cell
respons
spleen
mln
also
evalu
ic
observ
higher
proport
specif
antigenreact
cell
mln
oral
immun
compar
control
group
fig
addit
frequenc
cell
spleen
significantli
higher
group
vaccin
group
fig
similarli
proport
cell
mln
spleen
significantli
higher
group
oral
immun
fig
b
assess
regul
effector
cytotox
activ
vaccinationinduc
npand
cell
vivo
ctl
assay
perform
fig
mice
inocul
exhibit
higher
cytotox
function
oral
immun
mice
group
fig
henc
immun
effect
induc
aivspecif
ctl
cytotox
regularli
use
determin
antigenspecif
polyfunct
cell
induct
multifunct
cell
vaccin
may
relat
protect
leishmania
major
influenza
viru
challeng
therefor
also
perform
ic
analys
proport
specif
cytokineproduc
cell
observ
boost
mice
via
oral
rout
fig
higher
proport
peptidespecif
doubleposit
cell
detect
lung
mice
immun
fig
furthermor
spleen
proport
peptidespecif
cell
secret
cytokin
higher
mice
mice
belong
group
mice
fig
addit
higher
proport
tripleposit
cell
fig
detect
spleen
mice
immun
demonstr
improv
qualiti
cell
respons
evalu
cell
prolifer
respons
np
peptid
restimul
cell
analys
follow
oral
immun
recombin
l
plantarum
splenocyt
mln
dln
isol
differ
group
mice
one
month
final
vaccin
incub
np
peptid
vitro
fig
signific
cell
cell
prolifer
observ
respons
np
peptid
induct
spleen
mln
dln
isol
mice
vaccin
compar
isol
mice
vaccin
form
recombin
l
plantarum
inactiv
vaccin
fig
addit
data
indic
ratio
cell
notic
differ
spleen
group
howev
ratio
dln
mln
markedli
reduc
group
compar
control
group
fig
furthermor
cytokin
respons
observ
respons
np
peptid
restimul
mice
vaccin
belong
group
data
shown
determin
whether
protect
effect
transfer
cell
mouseadapt
aiv
nodscid
mice
associ
enhanc
specif
cell
respons
cell
isol
day
postvaccin
spleen
mln
mice
vaccin
pb
adopt
transfer
nodscid
mice
iv
tail
vein
inject
fig
significantli
lower
weight
loss
observ
mice
receiv
cell
day
day
p
p
compar
control
nodscid
mice
receiv
cell
fig
importantli
significantli
longer
surviv
time
obtain
nodscid
mice
adopt
transfer
cell
compar
found
control
nodscid
mice
p
fig
confirm
protect
provid
adopt
transfer
cell
cell
mice
cell
vaccin
mice
also
adopt
transfer
nodscid
mice
signific
differ
observ
group
viral
infect
nodscid
mice
receiv
cell
exhibit
extend
surviv
time
compar
control
nodscid
mice
fig
b
furthermor
cotransf
cell
fail
effici
protect
nodscid
mice
aiv
fig
result
indic
cell
protect
aiv
challeng
homolog
mouseadapt
aiv
infect
fig
signific
differ
weight
loss
observ
group
unpair
ttest
peak
weight
loss
observ
day
p
differ
weight
loss
group
inactiv
vaccin
group
signific
p
fig
addit
shown
fig
group
exhibit
surviv
challeng
lethal
dose
aiv
compar
group
logrank
mantelcox
test
p
control
group
logrank
mantelcox
test
p
respect
contrast
differ
surviv
group
inactiv
vaccin
control
group
signific
p
importantli
viral
load
lung
infect
log
log
lower
mice
immun
compar
load
observ
mice
antigenspecif
cytokin
secret
mln
splenocyt
mice
detect
two
week
oral
immun
b
number
spot
form
cell
sfc
mln
splenocyt
determin
use
elispot
assay
c
frequenc
antigenspecif
produc
cell
cell
mln
detect
flow
cytometri
data
mean
valu
sem
n
analys
use
oneway
anova
assum
gaussian
distribut
follow
dunnett
posttest
express
rel
pb
inactiv
vaccin
p
p
data
shown
repres
one
three
experi
equival
result
scientif
report
doi
vaccin
p
vaccin
p
respect
fig
consist
find
degre
lung
damag
challeng
aiv
reduc
mice
immun
compar
observ
mice
immun
pb
fig
c
determin
whether
type
influenza
vaccineinduc
immun
respons
mediat
protect
heterosubtyp
influenza
viru
infect
group
mice
oral
vaccin
challeng
day
later
heterosubtyp
strain
ld
repeat
test
util
lethal
dose
viru
observ
signific
differ
weight
loss
mice
challeng
ld
fig
vaccin
control
mice
succumb
infect
surviv
time
mice
vaccin
alway
longer
mice
receiv
pb
fig
c
abovedescrib
result
valid
challeng
smaller
dose
ld
vaccin
expect
control
mice
surviv
infect
mice
administ
day
prior
challeng
present
signific
improv
term
bodyweight
loss
vs
unpair
ttest
peak
weight
loss
observ
day
p
surviv
vs
logrank
mantelcox
test
p
fig
e
contrast
control
mice
mice
immun
exhibit
significantli
lower
residu
lung
viru
titer
infect
fig
furthermor
degre
lung
damag
challeng
significantli
reduc
mice
immun
compar
belong
group
fig
lung
section
score
three
independ
blind
reader
lung
inflamm
found
significantli
decreas
lung
infect
mice
vaccin
compar
pbsor
control
fig
result
directli
indic
oral
immun
l
plantarum
express
offer
effect
protect
heterolog
influenza
viru
infect
aiv
caus
seriou
econom
loss
poultri
industri
worldwid
addit
high
incid
mortal
aiv
also
threaten
mammalian
human
life
waterfowl
gener
consid
natur
reservoir
aiv
easili
transmit
virus
speci
poultri
via
migrat
transmiss
speci
like
requir
pivot
genet
antigen
mutat
specif
cell
respons
elicit
rel
well
conserv
intern
influenza
antigen
import
compon
inher
immun
influenza
particularli
heterosubtyp
aiv
howev
current
aiv
vaccin
provid
crossprotect
differ
subtyp
aiv
henc
develop
safe
efficaci
oral
vaccin
broader
spectrum
aiv
infect
poultri
activ
pursu
effort
intend
complet
control
viru
rather
allevi
clinic
symptom
reduc
viru
shed
acceler
recoveri
cellmedi
immun
respons
could
also
offer
much
broader
protect
combin
surviv
c
e
record
day
weight
loss
mortal
data
present
mean
sem
triplic
test
n
mice
per
group
weight
loss
data
analys
use
unpair
ttest
mortal
data
analys
use
logrank
mantelcox
test
express
rel
group
p
five
day
infect
mouseadapt
aiv
f
g
lung
titrat
mdck
cell
result
present
mean
sem
triplic
test
n
mice
per
group
analys
use
oneway
anova
assum
gaussian
distribut
follow
dunnett
posttest
express
rel
pb
inactiv
vaccin
group
p
p
p
data
shown
repres
one
three
experi
equival
result
histopatholog
score
lung
section
mice
lung
section
score
investig
blind
mous
ident
total
lung
inflamm
alveol
peribronchiolar
inflamm
scale
result
present
mean
sem
triplic
test
n
mice
per
group
signific
differ
analys
use
oneway
anova
assum
gaussian
distribut
follow
dunnett
posttest
express
rel
pb
p
p
p
humor
respons
play
critic
role
incomplet
protect
influenza
subtyp
includ
within
vaccin
importantli
partial
protect
subtyp
prevent
pandem
studi
conduct
laboratori
other
indic
lactobacillu
express
system
matur
effect
vector
express
aiv
antigen
allow
induct
stronger
immun
respons
pathogen
infect
addit
lactobacillu
induc
activ
dc
mln
small
intestin
cell
help
kill
pathogen
mous
model
studi
observ
recombin
l
plantarum
enhanc
express
dc
marker
vivo
vitro
importantli
oral
vaccin
mice
l
plantarum
express
also
effect
elicit
activ
dc
small
intestin
gradual
pp
mln
similar
result
obtain
kathania
data
confirm
dc
activ
effect
promot
cell
b
cell
differenti
potenti
contribut
rapid
pathogen
clear
host
mucos
vaccin
induc
stronger
mucos
immun
respons
great
signific
aiv
addit
siga
antibodi
key
effector
protect
mucosa
acquir
immun
respons
includ
gut
respiratori
tract
previou
studi
lactobacillu
gg
found
caus
enhanc
iga
product
wherea
l
johnsonii
lead
enhanc
iga
product
pp
wholeorgan
cultur
supernat
dc
may
associ
mechan
underli
enhanc
iga
product
l
plantarum
aya
furthermor
research
recent
demonstr
oral
administr
recombin
l
plantarum
may
contribut
product
secretori
iga
antibodi
mucos
surfac
respiratori
tract
combat
infect
pathogen
influenza
viru
studi
extend
earlier
find
determin
deliv
l
plantarum
significantli
elicit
iga
cell
pp
ileum
data
shown
result
indic
induc
significantli
higher
level
total
antigenspecif
secretori
iga
faecal
matter
balf
mice
cytokin
associ
differenti
b
cell
induct
iga
data
also
reveal
vaccin
recombin
l
plantarum
like
contribut
increas
number
fa
pna
b
cell
pp
mln
shape
gc
within
mucosa
mice
presum
recombin
l
plantarum
probiot
induc
follicular
helper
tfh
cell
contribut
celldepend
humor
immun
respons
provid
helper
cell
b
cell
contribut
gc
format
longliv
antibodi
respons
earlier
studi
suggest
antigenspecif
cell
respons
occur
vaccin
anim
patient
could
play
import
role
protect
immun
infect
pathogen
includ
aiv
produc
lymphocyt
result
enhanc
specif
kill
function
effect
attack
aiv
modul
chemotaxi
improv
antigen
present
elicit
immun
respons
aiv
infect
previous
publish
studi
chicken
vaccin
mva
adenoviru
incorpor
np
construct
report
markedli
improvedex
vivo
cell
elispot
respons
np
peptid
determin
elispot
assay
oral
administr
l
plantarum
express
significantli
enhanc
immun
spleen
mln
respons
stimul
np
epitop
interestingli
data
also
support
recent
find
secret
cell
provid
protect
immun
respons
influenza
viru
human
addit
cell
effici
respond
np
epitop
final
immun
data
indic
specif
cell
respons
might
associ
develop
protect
immun
oral
vaccin
recombin
l
plantarum
vaccineinduc
cell
might
offer
protect
lethal
influenza
viru
challeng
ctl
import
cell
type
mediat
surviv
mice
previous
demonstr
product
haspecif
cell
vitro
also
confer
protect
lethal
aiv
mouseadapt
infect
mice
indic
direct
role
cell
improv
mous
surviv
perforindefici
mice
exhibit
decreas
cytotox
activ
vitro
vivo
cell
cytolyt
combat
cell
infect
aiv
virus
gener
consid
main
role
perforin
could
induc
activ
result
complet
matur
effector
cell
specif
express
cell
critic
determin
phenotyp
cell
produc
immun
schedul
associ
protect
immun
respons
studi
observ
recombin
l
plantarum
elicit
product
ctl
activ
type
may
present
cytotox
activ
kill
target
np
peptid
vivo
data
consist
result
previou
studi
indic
immun
lactococcu
lacti
express
np
cholera
toxin
b
subunit
adjuv
mice
induc
signific
cellular
immun
respons
day
initi
immun
role
perforin
respons
await
confirm
futur
studi
evalu
potenti
improv
surviv
defici
perforindefici
mice
addit
studi
conduct
seder
group
suggest
vaccineinduc
multifunct
cell
secret
play
import
role
protect
influenza
viru
infect
shown
fig
data
display
higher
cytokin
induct
mice
group
treat
inactiv
vaccin
reason
find
may
cell
tissu
incub
mix
pool
np
peptid
antibodi
result
l
plantarumexpress
induc
antigenspecif
cytokin
inactiv
vaccin
base
surfac
antigeninduc
antibodi
immun
respons
find
consist
previou
research
show
signal
contribut
improv
surviv
effector
cell
lung
howev
inhibit
signal
time
effect
cell
infiltr
lung
markedli
decreas
effector
cytokin
secret
influenza
viru
challeng
mani
research
report
ratio
cell
indic
gener
immun
system
statu
data
indic
ratio
cell
markedli
chang
spleen
group
group
howev
ratio
scientif
report
doi
dln
mln
markedli
reduc
group
compar
control
group
specif
data
report
regard
role
differ
aiv
vaccin
ratio
dln
mln
recent
publish
studi
cell
tissu
cocultur
mix
pool
np
peptid
result
l
plantarumexpress
induc
antigenspecif
cell
cell
find
consist
prolifer
antigenspecif
cell
dln
intranas
influenza
administr
shown
fig
inject
cell
deriv
balbc
mice
pretreat
recombin
l
plantarum
nodscid
mice
improv
weight
loss
surviv
subsequ
challeng
mouseadapt
aiv
transfer
experi
nodscid
mice
provid
addit
evid
cell
cell
play
import
role
combat
influenza
virus
cell
respons
provid
strong
protect
influenza
viru
infect
furthermor
specif
cell
result
strong
pathogenkil
effect
thu
use
cell
studi
extens
howev
whether
cell
provid
protect
respons
influenza
viru
mice
vaccin
recombin
l
plantarum
via
mechan
await
studi
oral
administr
lactobacillu
shown
offer
effect
protect
influenza
viru
infect
mous
model
mice
oral
administ
heatkil
lactobacillu
pentosu
day
day
subsequ
inocul
influenza
viru
observ
protect
may
result
nonantigenspecif
immun
respons
lactobacillu
experi
howev
mice
immun
oral
recombin
l
plantarum
vaccin
vector
use
primerboost
regim
addit
mice
immun
start
recov
eight
day
challeng
mice
surviv
fig
b
indic
protect
effect
homolog
aiv
challeng
howev
immun
mice
challeng
ld
heterolog
viru
exhibit
effect
protect
recombin
l
plantarum
may
protect
mice
infect
epitop
np
subtyp
aiv
differ
therefor
although
recombin
l
plantarum
provid
limit
protect
infect
lethal
dose
heterolog
viru
provid
complet
protect
infect
subleth
dose
heterolog
viru
futur
studi
examin
conserv
vaccin
epitop
develop
effect
vaccin
differ
vaccin
found
offer
differ
immunoprotect
effect
inactiv
vaccin
target
aiv
surfac
protein
haemagglutinin
provid
complet
protect
homolog
aiv
fig
confer
partial
protect
heterolog
viral
strain
fig
humor
immun
respons
thought
provid
major
protect
effect
effect
strategi
aim
stimul
cell
respons
confirm
provid
protect
heterolog
influenza
viru
strain
mice
human
studi
oral
immun
l
plantarum
express
provid
effect
protect
heterolog
influenza
viru
infect
fig
addit
l
plantarumbas
vaccin
advantag
includ
protect
integr
lung
possibl
treg
markedli
improv
lung
mice
administ
l
rhamnosu
mani
studi
implic
agspecif
treg
primari
infect
addit
antigenspecif
memori
regulatori
cell
contribut
immun
regul
memori
respons
previous
encount
influenza
viru
play
import
regulatori
role
cellular
immun
respons
viral
infect
thought
prevent
patholog
chang
result
excess
immun
respons
conclus
result
demonstr
oral
administr
bacteri
vector
provid
protect
infect
lethal
dose
mouseadapt
aiv
subleth
dose
heterolog
viru
increas
mucos
adapt
immun
respons
oral
vaccin
result
signific
increas
dc
activ
specif
siga
antibodi
product
cell
induct
crossprotect
viral
challeng
vivo
western
blot
detect
np
antigen
express
l
plantarum
cultur
induc
gml
erythromycin
ngml
sakacin
p
sppip
previous
describ
cultur
h
recombin
l
plantarum
harvest
disrupt
ice
sonic
separ
sdspage
acrylamid
bacteri
protein
transfer
nitrocellulos
membran
incub
monoclon
mous
antinp
antibodi
secondari
horseradish
peroxidas
hrp
conjug
goat
antimous
antibodi
cell
signal
technolog
cst
wash
blot
visual
enhanc
chemiluminesc
ecl
thermo
scientif
amersham
imag
gener
electr
compani
immun
femal
balbc
mice
segreg
five
group
four
group
mice
receiv
pb
gavag
remain
group
mice
intramuscularli
administ
aiv
inactiv
vaccin
weik
biotech
china
lmous
brief
recombin
l
plantarum
cultur
mr
broth
contain
gml
erythromycin
ngml
sppip
h
anaerob
condit
freshli
cultur
recombin
l
plantarum
wash
phosphatebuff
salin
pb
resuspend
l
pb
administr
cfu
per
mous
recombin
l
plantarum
oral
administ
gavag
three
time
day
four
group
mice
receiv
three
booster
vaccin
four
week
later
day
mous
dc
cultur
flow
cytometri
mous
bone
marrowderiv
dc
induc
purifi
accord
publish
protocol
dc
activ
confirm
cocultur
mous
dc
ratio
h
dc
bone
marrow
tissu
label
allophycocyanin
apc
conjug
antibodi
clone
togeth
one
follow
clone
clone
clone
mhcii
clone
pna
cell
detect
previous
describ
use
bd
accuri
flow
cytomet
bd
bioscienc
data
analys
flowjo
softwar
elispot
assay
employ
previous
describ
murin
mln
cell
splenocyt
seed
coat
elispot
plate
mabtech
incub
np
peptid
final
concentr
gml
h
control
well
contain
peptid
incub
detect
antibodi
streptavidinhorseradish
peroxidas
gml
substrat
solut
ad
spotform
cell
sfc
detect
use
autom
spot
detect
devic
aid
intracellular
cytokin
stain
ic
ic
perform
previous
publish
protocol
leukocyt
clone
clone
bd
pharmingen
cell
fix
bd
cytofixcytoperm
kit
follow
manufactur
protocol
label
intracellularli
use
peconjug
clone
apcconjug
clone
fitcconjug
clone
isotyp
control
pe
apc
fitcconjug
antibodi
bd
pharmingen
final
sampl
analys
bd
fac
aria
ii
flow
cytomet
data
analys
use
flowjo
softwar
vivo
cytotox
assay
specif
cytotox
lymphocyt
ctl
assay
conduct
accord
publish
protocol
brief
splenocyt
isol
naiv
balbc
mice
divid
two
group
stain
carboxi
fluorescein
diacet
succinimidyl
ester
cfse
invitrogen
final
concentr
cfse
low
cfse
high
obtain
target
cfse
high
cell
incub
gml
np
peptid
h
wherea
cfse
low
cell
incub
peptid
cfse
high
cell
wash
mix
cfse
low
cell
ratio
total
cell
inject
mice
via
caudal
vein
h
cfse
high
cfse
low
stain
cell
splenocyt
group
mice
collect
detect
use
bd
accuri
bd
bioscienc
level
specif
kill
evalu
base
follow
formula
specif
kill
cfse
high
vaccin
cfse
low
vaccin
cfse
high
naiv
cfse
low
naiv
cell
prolifer
assay
assess
prolifer
prime
cell
murin
splenocyt
cell
dln
mln
stain
cfse
invitrogen
min
incub
either
np
peptid
posit
control
plate
h
incub
cell
label
apcconjug
peconjug
describ
bd
bioscienc
final
sampl
analys
use
bd
facsaria
ii
flow
cytomet
data
analys
use
flowjo
softwar
cell
isol
adopt
transfer
mln
spleen
balbc
mice
vaccin
pb
asept
collect
rpmi
gibco
fc
gibco
obtain
mln
cell
splenocyt
organ
gentli
crush
use
porefilt
bd
falcon
red
blood
cell
rbc
remov
use
ack
lysi
buffer
bd
pharm
lyse
tm
follow
posit
select
via
magnet
cellsort
column
mac
accord
manufactur
method
cell
incub
microbeadconjug
mab
miltenyi
analys
puriti
cell
purifi
cell
alon
purifi
cell
alon
equal
amount
cell
plu
cell
cellsmous
doptiv
transfer
spf
nodscid
mice
agematch
recipi
via
tail
vein
inject
four
week
booster
vaccin
anim
anesthet
intraperiton
ip
mgkg
mebubarbit
avertin
sigma
usa
group
mice
intranas
inocul
ld
mouseadapt
aiv
influenza
viru
adopt
transfer
h
group
recipi
nodscid
mice
inocul
ld
mouseadapt
aiv
anaesthesia
mice
challeng
viru
observ
daili
two
four
week
chang
weight
mortal
note
determin
tcid
viru
mous
lung
tissu
sampl
plate
madindarbi
canin
kidney
mdck
cell
incub
least
three
day
tcid
valu
determin
use
publish
protocol
weight
loss
consid
human
endpoint
mice
satisfi
standard
euthan
overdos
mebubarbit
previous
describ
histopatholog
detect
evalu
patholog
damag
lung
mouseadapt
viru
challeng
pulmonari
sampl
remov
mice
fix
paraformaldehyd
embed
paraffin
section
thick
stain
haematoxylin
eosin
h
e
score
blind
pathologist
three
independ
reader
briefli
alveol
peribronchiolar
inflamm
blind
score
ascal
correspond
none
mild
mild
moder
mark
sever
inflamm
respect
valu
repres
mean
standard
error
mean
sem
least
three
independ
experi
twotail
ttest
anova
employ
statist
analys
perform
use
graphpad
prism
softwar
mortal
analys
use
kaplanmei
method
logrank
test
p
consid
signific
